ProQR Therapeutics (PRQR) Capital Leases (2013 - 2015)

ProQR Therapeutics has disclosed Capital Leases across 3 years of filings, most recently posting $16.44 for Q4 2015.

• Capital Leases for Q4 2015 came in at $16.44, down 99.96% year-over-year; the trailing twelve-month figure through Dec 2015 was $16.44 (down 99.96% YoY), and the FY2015 annual result was $16.66, down 99.96% from the prior year.
• Capital Leases came in at $16.44 for Q4 2015 at ProQR Therapeutics, down from $33895.0 in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $65332.3 in Q4 2013 to a low of $16.44 in Q4 2015.
• The 3-year median for Capital Leases is $42494.3 (2014), against an average of $39231.4.
• Across the five-year window, Capital Leases sank 34.96% in 2014 and tumbled 99.96% in 2015, its largest moves.
• ProQR Therapeutics' Capital Leases stood at $65332.3 in 2013, then sank by 34.96% to $42494.3 in 2014, then sank by 99.96% to $16.44 in 2015.
• The last three Capital Leases figures came in at $16.44 (Q4 2015), $33895.0 (Q1 2015), and $42494.3 (Q4 2014), per Business Quant data.